Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Recurrence 1 Prostatic Neoplasms 1

Interventions

pembrolizumab 184 Carboplatin 132 Paclitaxel 101 Cisplatin 101 Gemcitabine 86 Pemetrexed 79 durvalumab 75 Nivolumab 66 Docetaxel 56 atezolizumab 52 Bevacizumab 50 Cyclophosphamide 49 Dexamethasone 45 Capecitabine 45 Oxaliplatin 43 130-nm albumin-bound paclitaxel 41 Rituximab 40 Fulvestrant 39 Lenalidomide 38 Fluorouracil 38 Prednisone 32 osimertinib 31 olaparib 29 Leucovorin 29 venetoclax 28 fludarabine 28 Trastuzumab 27 Doxorubicin 27 Etoposide 25 Cetuximab 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × INDUSTRY × PF06821497 × Clear all

NCT06551324 2026-05-05

MEVPRO-1

Pfizer

Phase 3 Active not recruiting

Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡